Doctor profile · Federal record
Dr. Roy Webb, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hot Springs, AR
- NPI 1346227048
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
133 Harmony Park
Hot Springs, AR 719135417
(501) 624-7700
fax (501) 623-5788 - Mailing address
-
Po Box 749495
Atlanta, GA 303749495
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- December 29, 2022
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arkansas #C16126
- Medicaid
- AR #110801001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346227048. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
174,539
Distinct HCPCS
10
Medicare allowed
$2,453,599
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 55,590 | 46 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 17,600 | 20 | $55 | |
J0185 |
Injection, aprepitant, 1 mg | 17,420 | 36 | $2 | |
J9299 |
Injection, nivolumab, 1 mg | 15,360 | 12 | $30 | |
Q5125 |
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 13,380 | 21 | $1 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,301 | 86 | $0 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,701 | 50 | $7 | |
J0897 |
Injection, denosumab, 1 mg | 5,400 | 26 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 4,715 | 11 | $0 | |
J9171 |
Injection, docetaxel, 1 mg | 4,304 | 13 | $1 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 2,867. This provider delivers 61× the peer median.Open Payments
Industry payments received
All-time total
$2,626
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $303.49 | |
| ABBVIE INC. | 10 | $290.84 | |
| Daiichi Sankyo Inc. | 9 | $199.33 | |
| Merck Sharp & Dohme LLC | 11 | $188.57 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $166.02 | |
| PFIZER INC. | 11 | $157.92 | |
| GlaxoSmithKline, LLC. | 6 | $119.79 | |
| Eisai Inc. | 4 | $104.13 | |
| Gilead Sciences, Inc. | 5 | $100.76 | |
| AstraZeneca Pharmaceuticals LP | 6 | $98.82 | |
| Astellas Pharma US Inc | 6 | $94.88 | |
| Janssen Biotech, Inc. | 5 | $93.10 | |
| Pharmacosmos Therapeutics Inc. | 5 | $70.92 | |
| Exelixis Inc. | 4 | $68.55 | |
| Incyte Corporation | 3 | $59.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
680
Patients
164
Total drug cost
$929,081
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamoxifen Citrate | Generic | 89 | 19 | $2,735 |
| Ondansetron Odt (Ondansetron) | Brand | 76 | 49 | $2,339 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 63 | 22 | $1,675 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 59 | 0 | $750,505 |
| Oxycodone Hcl | Generic | 55 | 12 | $1,338 |
| Letrozole | Generic | 49 | 14 | $1,152 |
| Promethazine Hcl | Generic | 45 | 32 | $374 |
| Gabapentin | Generic | 43 | 0 | $1,042 |
| Prednisone | Generic | 34 | 0 | $344 |
| Tramadol Hcl | Generic | 32 | 0 | $313 |
Hospital affiliations
Frequently asked questions
What is Dr. Roy Webb's medical specialty?
Dr. Roy Webb practices Hematology & Oncology Physician in Hot Springs, AR.
Where does Dr. Roy Webb practice?
Dr. Roy Webb practices at 133 Harmony Park, Hot Springs, AR 719135417. Office phone: 5016247700.
What is Dr. Roy Webb's NPI?
Dr. Roy Webb's National Provider Identifier (NPI) is 1346227048, issued by NPPES.
Does Dr. Roy Webb accept Medicare assignment?
Yes. Dr. Roy Webb accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Roy Webb commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.